The Interaction of Pentazocine and Pethidine in Anaesthetized Man
T. A. TOl{])A,* C. H. MCCULLOCHt AND A. J. KELLyt The 1'rinct ' Hcnry Hospital, ."·ydncy, and the School of Surger_\', L'nil' crsity of x.s. Jr., S~\'(ll/cy SC:\I:\IARY Pethidine] mg/kg and pentazocine ().f) mg/kg or 2 mg/kg were administered to subjects anaesthetized with thiopentone, nitrous oxide and oxygen. Cardiovascular and respiratory effects were studied. Pethidine 1 mg/kg and pentazocine 0·5 mg/kg were approximate Iv equidepressant. Pethidine] mg/kg prevented the depressant effects of subsequently administered pentazocine.
Pentazocine 2 mg/kg protected from the effects of pethidine, but pentazocine 0·5 mg gave only partial protection. Further work is necessarv to delineate the interaction of pentazocine with the narcotic analgesics, particularly with reference to the analgesic effects.
IXTRODl'CTIOX Because of its morphine-like potency (Keab and TeHord ] 964, Scott and Orr 19t19) yet lack of corresponding dependence liability (Fraser and Rosen berg 19t14) , pentazocine (Fortral, \Vinthrop) is an analgesic of major importance. As it is a narcotic antagonist rather than a narcotic analgesic, it is not unreasonable to be concerned about its interaction with narcotic analgesics.
Although Keats and Telford (19tl4) demonstrated no antagonism of morphine analgesia by pentazocine, Baskett and Diamond (1970) reported what appeared to be antagonism of phenoperidine by prior administration of pentazocine. A similar experience has been noted in our department (Vonwiller 1972) .
Rifat (1972) claims reversal of fentanyl-induced respiratory depression by pentazocine without antagonism of the analgesia, although the data supplied fall short of proof. This study set out to investigate the interaction of pentazocine with pethidine in anaesthetized human subjects.
The investigations were carried out on consenting adult patients in good general health. The subjects were given diazepam 15-20 mg with hyoscine 0 ,3-0,4 mg intramuscularly, for preoperative sedation. When the patient arrived in the anaesthetic room an intravenous infusion of Hartmann's solution was started, and all subsequent drugs were administered througn this drip. Before induction of anaesthesia the subject's pharynx was sprayed with 4 per cent li~nocaine to increase tolerance of a pharyngeal aIrway. Thiopentone was then injected slowly until an airway was easily inserted and tolerated. Nitrous oxide-oxygen mixture, 2 I. of each, was breathed by the subject through a well-fitting face mask from a Bode }lk III circle absorber incorporating a Wright respirometer. As soon as regular respirations showed that the subject had settled, the pulse rate, systolic and diastolic pressures were measured and the respiration rate and exhaled minute volume were recorded over a nO-second period. The test drug \\',b then .·/nllcs/liesill Illlli In/cJlsic'c Carl', 1'0/. T. Xo. ", Fl'imwrr. 1!1;:; '1', ,\, TOI{I>,\ ET AI.. injected over a Hi-second period, Further observations of the same parameters were recorded :~ minute:; and ti minutes after completion of the drug injection, At Ii minutes J;) seconds the ('hallenge drug (if am') was injected, again over If> second:;; observations were then recorded at 10 and 1:1 minutes,
The experimental design is shown in Tahle 1, Twent\'-five subjects (group 1) were giH'n pethidine, 1 mg/kg b()(h wcight, as the test drug, BP,S F 05 100 group C (10 subjecb) was challenged with pentazocine 0,;) mg/kg; the 10 patients in group :~ were gi\,(:'1l test doses of pentazocine :! mg/kg, five were used as controb (Sub-group A) and five received a challenge dose of pethidine I mg/kg (:;ub-group B), There wa:; no significant difference hetween the three groups as regards age, weight or initial observations,
The obsen'ations made on ea('h subject after the administration of drugs were ('onverted to a BP, D PR ~:~::~~ -' . (7), RESCLTS The results of the studies are set out in Tables . 
The Test J)YlIgs
Comparing group~ 1 and:2 (pethidin(' 1 mgjkg and pentazocine O':i mgjkg ,.;howc(l there were no significant differences between the control groups (lA and :2A), It is therefore justifiable to consider the two doses approximateh' equipotent, in the context of the parameters observed, \\'hen group 1 is contrasted with gronp :{, the blood prE'~sure wa" significantl\' high(,r, and RR 80 parallleter differed significantl\' from the control group, Challenge h\' pentazocine :2 mgjkg (L\ and 1 [)) caused a significant rise in diastolic pr('"sure and in pulse rate hut the respirato[\' parameters did not deviate significantly from th(lSl' of the control group, Comparison of the effects of challenge with a "('COI}(l close of pethidine with those of Jwnta-ZOCiTH' 0';-) mgjkg (lE and le) showed the ('i rculato[\' paramt'tch did not (li ffn signi ncant I \". Thl' respiratory effects of ],,'ntaz()cinl' and pdhidine, EI< n'spiratioll rate, ~I\' minute \'olull1l' \'t'ntilation, TI1l' ,co:raphs are arr;lnCO:I'd as in l'igure ], respiration rate and minute volume ventilation lower after pentazocine :2 mgikg than after pethidine 1 mg/kg (p. 0'0;;), The differences between groups::! and :~ (pcntazocine 0 ,;; mg/kg and pentazocine :2 mg/kg) wcre significant in all parameters (P <: () . 0:;).
.Ift,:r Challellge
The administration of a second do,.;e of pethidine (groups 1 A and 1 Il) cau,.;ecl a ,.;ignificant rise in pulse rate and respiration rate was further depressed, The challenge injection of pentazocine O·:i mg(kg (1 A and 1 c) caused a significant rise ;n s\'stolic pres,.;ure, :\0 other H()\\'e\'er, both re,.;piratioIl rate and minute \'oluIl1e were Il101T depre,.;sed by pethidine than pcntazocine (P' (I '0;;), Comparison of pethidine as a challenge drug with pentazocine :2 mgjkg (1 Band 1 D) showed greater respirator\' depression b\' pethidine, ChallengE'S wi t h the two dosage Ic\'els of pentazocine (le and Ill) ,.;howed no ,.;ignificant differences, Pethidine challenge of pentazocine O':i IIlg/kg (:2.\ and :2B) did not change the circulator~' parameters significantly, l:.(espiration rate was slowed, but tlw difference in minute volumes was not significant, :\ second do,.;e of pentazocine (:2"\ and :2c) resulted in grE'ater depression of the l'E:\TAZUCI:\E A:'\IJ PETHIIJI:'\E Il\TEl\ACTIo:\, :!39 respiratory rate hut none of the other measurements were significantly different. Comparison of the effects of repeated equipotent doses of pentazocine and pethidine (1 Band :.!c) showed the respiration rate and minute volume were more depressed by second doses of pethidine than pentazocine (P<O·Ol) .
When pentazocine :.! mgjkg was challenged with pethidine (3A and 3n) the effects were not significantly different from the control group.
There was no apparent arousal in any of the subjects when pethidine was challenged with pentazocine, or vice versa.
Drsccss[O:\
In this study equipotent doses of pethidine and pentazocine were compared. Each drug was then used to challenge the effects of the other. Control groups of each drug and groups to whom each drug was administered twice were used for comparison. A higher dose of pentazocine, four times the equipotent dose, was also used following pethidine, and vice 1'ersa, in an attempt to demonstrate antagonism.
The circulatory effects of the drugs were unremarkable.
Pethidine and pentazocine 0·5 mg/kg caused slight falls in blood pressure, systolic and diastolic, while pentazocine 2 mgjkg caused rises. The fact that a second dose of pethidine tended to elevate the blood pressure suggests that carbon dioxide retention may have been involved in the blood pressure rise, although there is some evidence which suggests an inotropic action (Levitski et al. 1(71) .
The effects of pethidine 1 mgjkg and pentazocine 0·5 mgjkg differed little. However, a second dose of pethidine given to pethidinetreated subjects caused a greater fall in ventilation rate and minute volume than repeated administration of pentazocine. Although this may be interpreted as a cumulative effect by pethidine due to longer duration of action (Davie et al. 197 ]), other interpretations are possible. If the dose-response cun·es of the two drugs were different in their slope, then doubling what were equipotent doses will lead to different effects. This possibilit\· has not been excluded.
Neither 0 ·5 mgjkg nor :.! mgjkg of pentazocine caused significant depression in respiratory rate or minute volume when administered to pethidine-treated subjr:cb, although both depressed these parameters significanth· when given to subjects who had had no pethidine. Pretreatment with pentazocine 0·;) mgjkg did not protect full~· against the respiraton· depressant action of pethidine 1 mgjkg but pentazocine 2 mgjkg did. Reversal of respiratory depression was not demonstrated.
It is concluded, therefore, that pretreatment with pethidine (lmgjkg) will protect from the respiratory depressant effects of up to 2 mgjkg of pentazocine: a sufficient dose of pentazocine also appears to protect subjects from respiratory depressant effects of pethidine. It is not known whether analgesia behaves similarly or not; experience with narcotic-antagonist mixtures suggests that this may be so (Campbell et al. 1965) , as do the reports of Baskett and Diamond (1970) . The work of Keats and Telford (1964) and the experience of Rifat (1972) suggest the contrary. For the present it is probably wise to avoid the sequential use of pentazocine and the narcotic analgesics in the same patient, as it seems possible that the combination may be unpredictable in its effect. Further work on the analgesic aspect of their interaction appears warranted. ACKXOWLEDGEMENTS \Ve are grateful to our surgical colleagues, whose helpful patience made this study possible. Sisters Coombes, Knight and Mason assisted with the studies and Mrs. P. Adams did the graphs and the many typescripts.
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